Insider Shareholders with Direct Ownership of Blueprint Medicines Corp (BPMC)
This section provides a comprehensive overview of the insiders with direct ownership of Blueprint Medicines Corp (BPMC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Blueprint Medicines Corp Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 20,601 | 9,815 | 58,026 $7.51 Million | 6 |
Jun 12, 2024
Added 3.72%
|
|
|
Christopher K. Murray
CHIEF TECHNICAL OPERATIONS |
44,000 | 23,995 | 33,853 $4.38 Million | 18 |
Mar 07, 2024
Reduced 6.93%
|
|
Anthony L. Boral
Chief Medical Officer |
19,183 | 10,000 | 28,147 $3.64 Million | 3 |
Dec 14, 2020
Reduced 0.76%
|
|
Marion Dorsch
Chief Scientific Officer |
16,778 | 16,778 | 15,250 $1.97 Million | 6 |
Feb 22, 2021
Reduced 33.2%
|
| 4,860 | 768 | 8,412 $1.09 Million | 5 |
Jun 21, 2022
Added 23.61%
|
|
|
Charles A Rowland Jr
Director |
23,159 | 20,909 | 5,812 $752,421 | 7 |
Jun 02, 2021
Added 27.91%
|
|
Tango Therapeutics, Inc.
Director |
3,400 | 0 | 3,400 $440,164 | 1 |
Dec 08, 2021
Added 50.0%
|
|
Mark Alan Goldberg
Director |
51,321 | 54,883 | 0 $0 | 19 |
Jul 17, 2025
Reduced 100.0%
|
|
Tracey L Mc Cain
EVP & Chief Legal Officer |
117,915 | 141,580 | 0 $0 | 19 |
Jul 17, 2025
Reduced 100.0%
|
|
Alexis Borisy
Director |
13,594 | 78,062 | 0 $0 | 6 |
Jul 17, 2025
Reduced 100.0%
|
|
Lonnel Coats
Director |
22,406 | 25,968 | 0 $0 | 9 |
Jul 17, 2025
Reduced 100.0%
|
|
Habib J Dable
Director |
12,644 | 12,644 | 0 $0 | 5 |
Jul 17, 2025
Reduced 100.0%
|
|
Jeffrey W. Albers
Director |
494,817 | 636,251 | 0 $0 | 82 |
Jul 17, 2025
Reduced 100.0%
|
|
Debra Durso Bumpus
Chief People Officer |
167,422 | 186,657 | 0 $0 | 27 |
Jul 17, 2025
Reduced 100.0%
|
|
Daniella Beckman
Director |
11,344 | 14,744 | 0 $0 | 5 |
Jul 17, 2025
Reduced 100.0%
|
|
Lynn Seely
Director |
13,594 | 17,156 | 0 $0 | 6 |
Jul 17, 2025
Reduced 100.0%
|
|
Percy H. Carter
Chief Scientific Officer |
95,446 | 95,446 | 0 $0 | 17 |
Jul 17, 2025
Reduced 100.0%
|
|
L. Becker Hewes
Chief Medical Officer |
114,789 | 132,289 | 0 $0 | 29 |
Jul 17, 2025
Reduced 100.0%
|
|
Christina Rossi
Chief Operating Officer |
120,343 | 140,708 | 0 $0 | 25 |
Jul 17, 2025
Reduced 100.0%
|
|
Ariel Hurley
Principal Accounting Officer |
56,463 | 67,887 | 0 $0 | 50 |
Jul 17, 2025
Reduced 100.0%
|
|
Fouad Namouni
PRESIDENT, R & D |
143,218 | 143,218 | 0 $0 | 16 |
Jul 17, 2025
Reduced 100.0%
|
|
Michael Landsittel
Chief Financial Officer |
131,096 | 148,446 | 0 $0 | 22 |
Jul 17, 2025
Reduced 100.0%
|
|
Kate Haviland
Chief Executive Officer |
316,315 | 359,153 | 0 $0 | 29 |
Jul 17, 2025
Reduced 100.0%
|
|
Philina Lee
Chief Commercial Officer |
101,274 | 121,628 | 0 $0 | 13 |
Jul 17, 2025
Reduced 100.0%
|
|
John Tsai
Director |
12,644 | 12,644 | 0 $0 | 5 |
Jul 17, 2025
Reduced 100.0%
|